Matching slides 58,039
Current window 32,251-32,280
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

32,251-32,280 of 58,039

filter-aware
26
Includes footnotes regarding anti-dilution provisions and Dong-A license agreement terms.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · Financials1 hit
08
The slide uses dot plots for IC50 values and a bar chart for tumor regression, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
The chart on the right uses a logarithmic scale for the Selectivity Index.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a process-flow style diagram to show how initial cohorts are expanded via back-filling and then filtered into a response-evaluable population.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
The slide presents baseline patient characteristics and prior treatment history for a clinical trial cohort.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
14
Data presented at ENA 2022. N=35 patients.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The chart displays a log-scale y-axis for concentration. The data supports once-daily (QD) dosing based on a 20h half-life.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Clinical trial data presentation for ENA 2022.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate drug efficacy.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
18
The chart is a swimmer plot (often used in oncology to show duration of response/treatment).Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
19
Includes a spider plot (waterfall-like over time) and a bar chart showing allele clearance.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
26
The slide uses a combination of scatter plots, bar charts, and a waterfall-style selectivity chart to demonstrate drug efficacy and safety profile.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
27
The slide compares vehicle control vs NVL-655 treatment across multiple cell lines and a patient-derived xenograft (PDX) model.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
28
The slide uses a structured table to define patient eligibility criteria for different cohorts in a clinical trial.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
05
The slide uses a combination of absolute revenue growth and YoY percentage trends to demonstrate business stabilization.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Need1 hit
09
Includes footnotes regarding non-GAAP measures and continuing operations.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Need1 hit
10
The chart includes a trend line annotation showing a 33% decline from Q3 '21 to Q3 '22.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The chart displays a dual-axis view of gross margin performance over time.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart uses a combination of bar (absolute $) and line (percentage) to show trends.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The chart highlights a decline in both absolute EBITDA and margin percentage over the two-year period.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The chart combines a bar chart for active customers and a line chart for order frequency.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The chart displays a decline in order volume alongside an increase in average order value.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide uses a before-after framing to isolate the impact of 'non-home only' customers on overall performance metrics.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide uses a clear layout to contrast balance sheet status with specific capital allocation activities.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
33
Includes a sub-table for 'Special items' and a disclaimer regarding non-GAAP financial measures.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations 1 hit
34
The table reconciles GAAP Diluted EPS to an Adjusted Diluted EPS figure by adjusting for equity method income/loss.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations 1 hit
06
The charts highlight adjusted earnings for 2022 compared to GAAP earnings.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Desire1 hit
07
The slide uses a combination of big numbers for cumulative totals and an area chart to show the reduction in share count over time.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Desire1 hit
09
The diagram is a circular process flow showing four key drivers.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
10
The slide presents a comparative income statement for 4Q21, 3Q22, and 4Q22.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · ActionLoop · Zoom In1 hit